About: Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 22 January 2005

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2005 (fr) наукова стаття, опублікована в березні 2005 (uk) im März 2005 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2005 (ast) scientific article published on 22 January 2005 (en)
publication date	wds:Q59617826-2444336E-2486-4389-9980-2116628A49FD
publication date	2005-01-22 00:00:00Z (xsd:dateTime)
author name string	wds:Q59617826-1214CB6B-0587-459B-B55A-839B11683AB6 wds:Q59617826-15BDABB9-15C4-48A6-9567-461B487FEC21 wds:Q59617826-2DA99541-BF72-43EE-B960-8ABA4EBA2E4E wds:Q59617826-544D71F0-4C52-451E-82FE-5D61B6CD562A wds:Q59617826-826F5684-6AC1-4048-97BA-5DAA6354048E wds:Q59617826-9817DDBA-69D6-4A9A-B8EC-D2617AF7A140 wds:Q59617826-B0AC30B2-D1C3-4E7A-B877-ED8C46F06892 wds:Q59617826-C0351F1C-923D-4009-8449-0603CBD84A16 wds:Q59617826-C0391611-A952-4FE2-8D77-CC7FB7F2622C wds:Q59617826-C15BBC86-018A-4C44-96FC-D08AFCE8B56E wds:Q59617826-C2577167-4D2F-446E-88A9-06BBCE2184B5 wds:Q59617826-C37EC869-EDEC-4906-9496-A8F99159AD42 wds:Q59617826-CA0D58EA-5C63-4586-8BEE-A639BF542D32 wds:Q59617826-D5DA729F-5DA0-44C2-92F6-F8AEB200C933 wds:Q59617826-E3361B5E-C855-4DFF-B335-F45C428FFEA9
author name string	Manfred Herold Jamal Zweit Gerard Groenewegen Malcolm Ranson Sandrine Marreaud Heinz Zwierzina Jeremy Lawrance Dan Levitt Clive Mulatero Frederic F Lehmann Leif Hakansson Linda Wauk Lynn Broughton Meina Tang European Organisation for Research and Treatment of Cancer (EORTC)
rdfs:label	Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer (en) Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer (nl)
skos:prefLabel	Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer (en) Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer (nl)
name	Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer (en) Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer (nl)
author	wds:Q59617826-310C3682-CC98-4B4A-9D2D-864427697050 wds:Q59617826-DD758DE8-9C0F-4D82-8590-4E0C8E9FDF8A wds:Q59617826-FCA47C81-6A6E-4A9E-A034-73EE70CA5C46
author	Gordon C. Jayson John Wagstaff Alan Jackson
title	wds:Q59617826-1083C177-A72F-4060-A90B-AB15B0A14531
title	Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer (en)
page(s)	wds:Q59617826-AFA3B598-C955-46B6-827F-A2F7C06689D4
page(s)	555-563
instance of	wds:Q59617826-46AF5890-7677-4BA3-9E75-4328D1C273C4
instance of	scholarly article
PubMed ID	wds:Q59617826-EB2966FB-2A9B-481C-826E-A133DF1199B5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15737560
PubMed ID	15737560
published in	wds:Q59617826-25C11C94-95EF-48A5-A2F9-8C12F03A2FC9
published in	European Journal of Cancer
issue	wds:Q59617826-9300CF14-0C11-43BB-BF93-1D3A28CC6626
volume	wds:Q59617826-46F7A808-9DE2-4214-8447-6AE622BBC4BB
issue	4
volume	41
DOI	wds:Q59617826-CBB23E24-9622-4541-B62D-04B033E11345
DOI	http://dx.doi.org/10.1016/J.EJCA.2004.11.021
DOI	10.1016/J.EJCA.2004.11.021
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59617826
is cites work of	Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors. Engineered monoclonal antibody with novel antigen-sweeping activity in vivo. The VEGF pathway in cancer and disease: responses, resistance, and the path forward. Targeting angiogenesis: progress with anti-VEGF treatment with large molecules Targeting the tumor microenvironment: focus on angiogenesis Biomarkers of angiogenesis and their role in the development of VEGF inhibitors Applying physiological and biochemical concepts to optimize biological drug development. Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering. Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer Antivascular therapy for epithelial ovarian cancer
is cites work of	wds:Q51722492-F5CAEB5B-BCE5-4639-AD1A-0D4C7943BCAC wds:Q37654773-F25F2F71-074C-43A6-ADF9-5970023A412E wds:Q35184806-01996628-3B0B-4F54-A033-720E5D751F1C wds:Q33583598-27C55D31-45AE-4640-AECD-52A2C5715151 wds:Q36286704-87811807-EEBA-4257-AC50-850A67E2FFC1 wds:Q37052713-7AC12682-0E80-45BA-B54D-A54A3E7BDCFB wds:Q36526512-7CFC3D31-AAF2-4F69-BE4D-D130635849D9 wds:Q34718085-39428FDD-7BBC-4B8E-A003-1CA4CA95438A wds:Q37563976-4348E290-431A-4E15-856F-B74385CE08F6 wds:Q42584647-DDEBDBAE-5004-4850-A6AD-C8CB412046DD

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software